NCT04456972View on ClinicalTrials.gov

Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 19, 2020

Primary Completion Date

January 8, 2022

Study Completion Date

January 8, 2022

Conditions
Circulating Tumor DNAEndometrial Cancer
Interventions
DIAGNOSTIC_TEST

One arm only

Samples of plasma to analyze ctDNA

Trial Locations (1)

Unknown

CHU Poitiers, PRC, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT04456972 - Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers. | Biotech Hunter | Biotech Hunter